🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Fibrosis, Pulmonary

Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis NCT07809867Phase 41 site📍 Genova Istituto Giannina Gaslini · Tests: Elexacaftor, Tezacaftor, Ivacaftor, Ivacaftor (VX-770) A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring NCT06797206n/a1 site📍 London Royal Brompton & Harefield NHS Foundation Trust Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases NCT06537934n/a1 site📍 Milan IRCCS San Raffaele Study of the Prevalence of Active/Passive Smoking and Vaping Among Patients With Cystic Fibrosis NCT07342920n/a1 site📍 Strasbourg University Hospital, Strasbourg, France Estrogen Supplementation and Bone Health in Women With CF NCT05704036Phase 41 site📍 Baltimore Johns Hopkins University · Tests: Transdermal estrogen, Progesterone Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis NCT05310669n/a1 site📍 Modena University of Modena and Reggio Emilia · Tests: Nasal pressure assessment Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies NCT01776398n/a1 site📍 New York Weill Medical College of Cornell University Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury NCT04485286Phase 21 site📍 Boston Massachusetts General Hospital · Tests: [68Ga]CBP8 AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF NCT07194382Phase 249 sites📍 Camperdown📍 Kingswood📍 New Lambton Heights Avalyn Pharma Inc. · Tests: AP02, Placebo CF Wellness Program NCT07071324NA3 sites📍 Denver📍 Baltimore📍 Boston Johns Hopkins University · Tests: CF Wellness Program A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients NCT05139719Phase 21 site📍 Beijing Sunshine Lake Pharma Co., Ltd. · Tests: HEC585 dose A, HEC585 dose B, Placebo Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis NCT06602869n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Scheduled visit (V1) Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short Pause of Therapy NCT05818319NA1 site📍 Aarhus C University of Aarhus · Tests: 12 hours ETI pause, 36 hours ETI pause, 60 hours ETI pause Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis NCT06747858Phase 213 sites📍 Tucson📍 Little Rock📍 Los Angeles Arcturus Therapeutics, Inc. · Tests: ARCT-032 Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF) NCT06488638NA1 site📍 Southampton University Hospital Southampton NHS Foundation Trust · Tests: nitrate-rich beetroot juice (70ml with approx. 400 mg nitrate) twice a day for 3 days P4O2 ILD Extension NCT06644144n/a1 site📍 Amsterdam Amsterdam UMC, location VUmc · Tests: No Interventions A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis NCT06132048NA1 site📍 Rouen Ad scientiam · Tests: MuCopilot mobile application Kidney Function in People With Cystic Fibrosis in the Era of HEMT NCT06595420n/a3 sites📍 Birmingham📍 Lebanon📍 Charlottesville University of Virginia Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases NCT06189820Phase 21 site📍 Brussels Erasme University Hospital · Tests: FAPI PET/CT Evaluation of VX-581 in Healthy Participants and in Participants With Cystic Fibrosis NCT07283770Phase 11 site📍 Overland Park Vertex Pharmaceuticals Incorporated · Tests: VX-581, Placebo, D-IVA, TEZ, ELX/TEZ/IVA Sinus Disease in Young Children With Cystic Fibrosis NCT06191640n/a6 sites📍 Aurora📍 Iowa City📍 Kansas City University of California, Los Angeles · Tests: Ivacaftor or elexacaftor/tezacaftor/ivacaftor Validation of the C-mo System - Cough Monitoring NCT05989698NA8 sites📍 Alfena📍 Amadora📍 Aveiro Cough Monitoring Medical Solutions · Tests: C-mo System Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF) NCT05998629NA1 site📍 Hershey Milton S. Hershey Medical Center · Tests: a skin-interfaced colorimetric bifluidic sweat device with two synchronous channels, Standard of Care laboratory proced… Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CT NCT07761377n/a1 site📍 Taichung Taichung Veterans General Hospital · Tests: AccuPulmo CT Portal Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial NCT06457451NA4 sites📍 Angers📍 Roscoff📍 Tours University Hospital, Tours · Tests: DIAPASOM program GRAnulomatous MAstitis REGistry Study NCT07422870n/a2 sites📍 Düsseldorf📍 Lübeck European Breast Cancer Research Association of Surgical Tri… A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF) NCT06526923Phase 1, Phase 24 sites📍 Kansas City📍 Boston📍 New York Spirovant Sciences, Inc. · Tests: SP-101 and doxorubicin Cohort 1, SP-101 and doxorubicin Cohort 2 Western Sweden Systemic Sclerosis Project NCT07345052n/a1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: No Intervention: Observational Cohort European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank NCT02852928n/a3 sites📍 Hanover📍 Ankara📍 Edinburgh Matthias Griese
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy